NCT04284189 Aftercare of Childhood Cancer Survivors in Switzerland
| NCT ID | NCT04284189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kantonsspital Aarau |
| Condition | Childhood Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 140 participants |
| Start Date | 2019-02-12 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 140 participants in total. It began in 2019-02-12 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.
Eligibility Criteria
Inclusion Criteria: * 5-year survivor of childhood cancer * Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH) * Age at diagnosis \<18 years * Age at study ≥16 years * At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition). * Written informed consent Exclusion Criteria: * Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma) * \<5 years after therapy of a relapse or palliative situation * Severe cognitive impairment, which makes it impossible to complete the questionnaire independently * Insufficient knowledge of the German language * Informed consent form not signed
Contact & Investigator
Katrin Scheinemann, MD
PRINCIPAL INVESTIGATOR
Kantonsspital Aarau
Frequently Asked Questions
Who can join the NCT04284189 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04284189 currently recruiting?
Yes, NCT04284189 is actively recruiting participants. Contact the research team at katrin.scheinemann@ksa.ch for enrollment information.
Where is the NCT04284189 trial being conducted?
This trial is being conducted at Aarau, Switzerland, Basel, Switzerland, Lucerne, Switzerland.
Who is sponsoring the NCT04284189 clinical trial?
NCT04284189 is sponsored by Kantonsspital Aarau. The principal investigator is Katrin Scheinemann, MD at Kantonsspital Aarau. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.